Table 9 Anti-malarial dr ug treatment and outcome
From: Prognostic indicators in adults hospitalized with falciparum malaria in Western Thailand
Variable | All | Alive | Died | |||
|---|---|---|---|---|---|---|
|  | +/− | % | +/− | % | +/− | % |
Non-artemisinin/artemisinin derivative therapy | 580/378 | 60.5 | 521/362 | 59.0 | 59/16 | 78.7 |
Parenteral quinine/artemisinin derivative. Patients given both parenteral quinine and artemisinin derivatives excluded | 430/276 | 60.9 | 371/261 | 58.7 | 59/15 | 79.7 |
Oral quinine/artemisinin derivative and no parenteral anti-malarial | 93/60 | 60.8 | 93/60 | 60.8 | 0/0 | - |
Number given/not given antibiotic a | 124/818 | 13.2 | 94/778 | 10.8 | 30/40 | 42.9 |
No. given/not given inotrope | 65/872 | 6.9 | 13/856 | 1.5 | 52/16 | 76.5 |
No. given/not given anti-epileptic drug | 97/843 | 10.3 | 59/812 | 6.8 | 38/31 | 55.1 |
No. given/not given nasogastric tube | 65/859 | 7.0 | 36/828 | 4.2 | 29/31 | 48.3 |
No. given/not given urinary catheter | 207/728 | 22.1 | 142/725 | 16.4 | 65/3 | 95.6 |
No. given/not given blood transfusion | 160/828 | 16.2 | 132/779 | 14.5 | 28/49 | 36.4 |
No. given/not given dialysis | 31/898 | 3.3 | 7/854 | 0.8 | 24/44 | 77.4 |
No. given/not given ventilation | 85/845 | 9.1 | 25/839 | 2.9 | 60/6 | 90.9 |
No. given/not given central venous access line | 99/840 | 10.5 | 45/825 | 5.2 | 54/15 | 78.3 |
No. given/not given lumbar puncture | 90/849 | 9.6 | 56/813 | 6.4 | 34/36 | 48.6 |
No. developing/not developing pulmonary oedema | 14/958 | 1.4 | 7/888 | 0.8 | 7/70 | 9.1 |
No. developing/not developing oliguria | 94/843 | 10.0 | 43/826 | 5.0 | 51/17 | 75.0 |
No. developing/not developing seizures | 39/909 | 4.1 | 20/852 | 2.3 | 19/57 | 25.0 |
No. of nights in hospitalb | 4 (1–34) | - | 4 (1–34) | - | 2 (1–27) | - |
Coma Recovery Time/hb | 24 (1–188) | - | - | - | - | - |
Time to death/hb | - | - | - | - | 44 (2–641) | - |